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ABSTRACT
Objective: Pharmacological and genetic inhibition of p38α mitogen-activated protein kinase (p38α MAPK) has potential in the treatment of human 
diseases such as autoimmune diseases, heart failure, Alzheimer disease, and Parkinsonism. Our aim is to do in-silico screening of phytochemicals of 
Morinda citrifolia for p38α MAPK inhibitory property by docking method.
Methods: We did docking of various phytochemicals present in M. citrifolia against p38α MAPK enzyme extracted from Protein Data Bank (ID-4F9Y), 
by utilizing the Molegro virtual docker Software. The docking scores of phytochemicals were compared with the scores of native reference ligands 
present in the crystal structure 4F9Y.
Results: Isoprincepin and balanophonin show better docking scores when compared to reference ligands in the protein. Isoprincepin has potential 
to act in a highly selective manner on p38α MAPK as it binds to Met 109 in the phylogenetically conserved kinase hinge region and thereby induces a 
conformational change known as glycine flip phenomenon. Balanophonin has favorable physiochemical properties for blood-brain barrier penetration 
and can act on p38α MAPK in the brain.
Conclusion: Some of the phytochemicals present in M. citrifolia have p38α MAPK binding and possible inhibitory potential.
Keywords: p38α mitogen-activated protein kinase, Isoprincepin, Balanophonin, Molegro virtual docker.
INTRODUCTION
Mitogen-activated protein kinase 14 (MAPK 14), also called p38α MAPK 
is an enzyme that in humans is encoded by the MAPK 14 gene [1]. 
MAPK 14 gene encodes p38α MAPK which is the prototypic member 
of the p38 MAPK family. p38 MAPKs are also known as stress-activated 
serine/threonine-specific kinases. In addition p38α, the p38 MAPK family 
has three additional members’ p38β, p38γ, and p38δ isoforms, encoded 
by MAPK 11, MAPK 12, and MAPK 13 genes, respectively. p38α MAPK 
was originally identified as a tyrosine phosphorylated protein detected in 
activated immune cell macrophages with an essential role in inflammatory 
cytokine induction, such as tumor necrotic factor α (TNF-α) [2,3]. However, 
p38α MAPK is ubiquitously expressed in many cell types [4,5] and p38α 
mediated kinase activity has been implicated in many functions beyond 
immune system. Pharmacological and genetic inhibition of p38α not 
only revealed its biological significance in physiological function but also 
the potential of targeting p38α in human diseases such as autoimmune 
diseases, heart failure, Alzheimer disease, and Parkinsonism.
Role of p38α MAPK in heart failure
p38α MAPK activity is implicated in cardiac hypertrophy which is a 
significant feature of pathological remodeling in the diseased hearts 
and a major risk factor for heart failure and adverse outcomes [6-9]. 
Chronic activation of p38α MAPK activity is viewed as pathological and 
pro-apoptotic, and its inhibition is in clinical evaluation as potential 
therapy to mitigate acute ischemic injury in ischemic heart failure and 
against reperfusion injury after revascularization [10-12].
Role of p38α MAPK in Alzheimer’s disease and Parkinsonism
Alzheimer’s disease is the most common form of dementia and is 
becoming increasingly prevalent with an estimation that 1 in 85 
people globally will be affected by 2050 [13]. The disease is typically 
characterized by the presence of Aβ plaques or neurofibrillary 
tangles (NFTs) formed from free aggregated neuronal microtubule-
associated protein “Tau’ within the brain. Tau has been shown to be 
phosphorylated by p38α MAPK in neurons. Tau is a highly soluble 
microtubule-associated protein in which sub-cellular localization 
is determined by its phosphorylation status in neuronal cells. 
The principal function of tau is to bind and stabilize cytoskeleton 
microtubules (MTs). The ability of tau to interact with and stabilize 
MT is regulated through post-translational modifications, mainly 
through phosphorylation of serine and threonine residues. This 
regulatory phosphorylation is tightly controlled by numerous protein 
phosphatases and kinases, and consequently by p38α MAPK [13,14]. 
The phosphorylation of particular residues Ser-356, Thr-231 and Ser-
235 has been proposed to instigate detachment of tau from the MT, and 
since these residues has been shown to be phosphorylated by p38α 
MAPK; it could potentially be involved in tau detachment from MT and 
thereby destabilization of the MT [14-18]. Physiological role of p38α 
MAPK in tau phosphorylation can turn into a pathophysiological role 
if tau becomes hyperphosphorylated, as this hyperphosphorylation 
results in increased tau detachment from MT, then there is an increase 
in the amount of soluble tau present in the neuron, which is therefore 
prone to self-aggregation and polymerization, leading to the formation 
of tau oligomers. These oligomers combine and further aggregate 
to form paired helical filaments which then assemble to form Aβ 
amyloid containing plaques or NFTs as seen in Alzheimer’s disease. In 
addition to the aforementioned association with plaques and tangles, 
p38 MAPK is involved with the inflammatory response. It was shown 
that Aβ amyloid is able to stimulate glial cell cultures and activate 
p38α MAPK [19], thus upregulating the production of inflammatory 
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cytokines such as interleukin-6 (IL-6), IL-1β and TNF-α [20,21]. It is 
this increased release of inflammatory mediators from overstimulation 
of Aβ-stimulated glial cells that can cause a neuroinflammatory and 
neurotoxic effect on surrounding neurons contributing to the loss of 
neurons witnessed in neurodegenerative disease [22]. Similar injury to 
neurons by inflammation is also seen in Parkinson’s disease. α-Synuclein 
is the predominant fibrillar component of the proteinaceous Lewy 
bodies seen in Parkinson’s disease. α-Synuclein released from damaged 
neurons interacts with microglia and the activation of glial cells through 
the p38α MAPK consequently results in the production of inflammatory 
cytokines and TNF-α, which promote neuroinflammation [23].
Role of p38α MAPK in inflammation
Activation of MK2 (MAPK activated protein kinase-2) by p38α MAPK 
plays a pivotal role in upregulating the secretion of inflammatory 
cytokines, IL6, IL-1β and TNF-α by immune cells [24]. Hence, drugs 
targeting p38α MAPK have potential for autoimmune diseases like 
psoriasis, rheumatoid arthritis, etc. apart from neurodegenerative 
diseases and ischemic heart failure.
Anti-inflammatory and neuroprotective actions of Morinda citrifolia
The M. citrifolia plant is one of approximately 11,000 species of 
the family Rubiaceae. Furthermore known as the Indian mulberry, 
BaJiTian, cheese fruit, and various other names in different countries. 
It is a popular plant used for curative and preventive purposes in 
Polynesia as almost all of its parts in various combinations have been 
used to treat various known acute and chronic diseases in this region 
for 2000 years [25,26]. The anti-Alzheimer effect of an ethyl acetate 
extract of M. citrifolia fruits was studied by Muralidharan et al. in a 
mouse model. It was shown that the extract ameliorated beta-amyloid 
peptide induced cognitive dysfunction in mice and there was significant 
increase in short-term memory, and long-term memory as observed by 
the step-down inhibitory avoidance behavior and significant decrease 
in escape latency was noticed in the animals treated with extract in the 
water maze [27]. Xu et al. showed that feeding of extract of M. citrifolia 
fruits to neonatal foals (newborn horses) decreased monocyte 
expression of TNF-α and cyclooxygenase-2 [28]. In BALB/c mouse 
model Hokama et al. showed that alcohol extract of M. citrifolia fruit 
at various concentrations inhibited the production of TNF-α, thereby 
inhibiting its tumor promoting effect [29].
Thus, various experimental evidences have shown that M. citrifolia 
has anti-inflammatory and anti-Alzheimer properties. The extract of 
M. citrifolia is a mixture of various phytochemicals.
The molecular mechanisms by which M. citrifolia extract exerts 
neuroprotection and inhibition of cytokine production actions have 
not been studied in detail so far. Currently, molecular docking approach 
has been used in modern drug design and to understand drug-receptor 
interactions. This paper reports screening of various phytochemicals 
present in M. citrifolia against p38α MAPK enzyme extracted from 
Protein Data Bank (PDB), by utilizing the Molegro virtual docker (MVD) 
Software [30].
METHODS
The structure of p38α MAPK (PDB ID 4F9Y) was obtained from the PDB 
(http//www.rcsb.org). The structure contains ligands MW181 (C21 H18 N4; 
N,N-dimethyl-6-(naphthalen-1-yl)-5-(pyridin-4-yl)pyridazin-3-amine 
or MW01-10-181SRM) and GG5 (C14 H10 FN3, 4-[3-(4-fluorophenyl)-1H-
pyrazol-4-yl]pyridine) co-crystallized to p38α MAPK. In vitro and in vivo 
assays demonstrated that MW181 ameliorates beta-amyloid-induced 
synaptic and cognitive dysfunction. The active site targeting of the 
inhibitor was confirmed by high-resolution crystallographic analysis, 
and the structure has been deposited with RCSB-PDB to facilitate future 
kinase inhibitor design [31].
Literature search was done which revealed phytochemicals present in 
M. citrifolia fruit reported by various authors. Major iridoids present 
in M. citrifolia fruit are asperuloside and asperulosidic acid. Minor 
iridoids of M. citrifolia include dehydro-methoxy gaertneroside, epi-
dihydrocornin, 6-alpha-hydroxyadxoside, citrifolinin-B, and 7-beta-
epoxy-8-epi-splendoside. Flavanol glycosides present in the fruit 
are rutin, narcissoside, and nicotifloroside. Several known and new 
lignans like 3,3’-bisdemethylpinoresinol, americanol-A, americanin, 
isoprincepin, and balaphonin are also present. Miscellaneous 
compounds such as J-Sitosterol and its 3-O-glucoside, ursolic acid, 
19-hydrosyursolic acid, cytidine, borreriagenin, epiborreriagenin, 
4-hydroxy-3-methoxycinnamaldehyde, hydroxypropiovanillone 
and vanillin have been isolated from the fruit [32]. Vomifoliol [33], 
austrocortinin [34], pinoresinol and quercetin [35], rubiadin and 
nordamnacanthol [36], morindone-5-O-methyl ether [37], are also 
present in M. citrifolia fruit.
Of the above 32 principle compounds present in fruit 22 molecules 
which satisfy at least 4 conditions of the Lipinsky 5 rule (molecular 
weight ≤500 g/mol, oil/water distribution coefficient (Log P) ≤5, 
hydrogen bond donors ≤5, hydrogen bond acceptor ≤10, number of 
rotatable bonds ≤10) [38] were selected for docking. The structure 
of these compounds was downloaded as SDF files from Pubchem 
compounds database. To make accurate predictions, it is important that 
the imported structures have been properly prepared, that is, the atom 
connectivity and bond orders are correct and partial atomic charges are 
assigned. SDF files often have the poor or missing assignment of explicit 
hydrogens. All necessary valence checks and H atom addition were thus 
performed using the utilities provided in MVD.
MVD automatically identifies potential binding sites (also referred as 
cavities or active sites) by using its cavity detection algorithm. The 
cavitiescentered at the experimentally known ligand position were 
used. In the case of the crystal structure of p38α MAPK, the program 
identified five different binding sites. From these five predicted cavities, 
Cavity 1 with the highest volume containing bound ligand MW181 and 
Cavity 2 containing bound ligand GG5 were selected for docking. Native 
ligands were extracted and redocked into appropriate active sites. The 
results yielded control parameters for comparing with M. citrifolia 
phytochemicals. Docked native ligands were viewed in workspace and 
were found to have optimal orientation.
Ten independent runs were performed for each ligand with the guided 
differential evolution algorithm, with each of these docking runs 
returning one solution (pose). The Moldock scoring function used 
by MVD is derived from the scoring functions originally proposed by 
Gehlhaar et al. and extended later by Yang et al. [39]. The 10 solutions 
obtained from the 10 independent docking runs were re-ranked, to 
further increase the docking accuracy, using a more complex scoring 
function. The mean and standard deviation of the scores were 
calculated. The docking scores of Morinda phytochemicals in Cavity 1 
and Cavity 2 were validated by comparing them with the docking scores 
of MW181 and GG5, respectively. In the studies reported here, MVD was 
used because it showed higher docking accuracy when benchmarked 
against other available docking programs (MD: 87%, Glide: 82%, 
Surflex: 75%, FlexX: 58%) (Figs. 1 and 2) [30].
RESULTS AND DISCUSSION
Cavity 1, reference ligand MW181
Among 22 compounds docked, compound isoprincepin (C27 H26 O9, 
moldoc score −141.14±3.39 kcal/mol) showed better docking score, 
and rerank score compared to reference ligand MW181 (moldoc score 
−111.29±8.20 kcal/mol) present in Cavity 1 in the crystal structure. 
Negative values indicate that the bond is more stable. Higher negativity 
means the bond is more stable and the interaction may hinder the 
performance of the enzyme (Table 1).
A recently emerging variant of the active site approach focuses 
on induction of localized conformational changes by inhibitorsto 
achieve selectivity. In the case of p38α MAPK inhibitors, the approach 
is by exploiting hydrogen (H)-bond interactions with the Met109 
amide bond in the phylogenetically conserved kinase hinge region 
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that can also engage the contiguous Gly110, thereby inducing a 
localized conformational change, termed as glycine flip [40-43]. In 
our study isoprincepin showed similar H-bond interaction with Met 
109 amide bond and hence can be expected to have high selectivity 
(Figs. 3 and 4).
Cavity 2: Reference ligand GG5
Isoprincepin and balanophonin (C20 H20 O6) show better docking scores 
when compared to reference ligand GG5 in Cavity 2 (Table 2) and the 
compounds have hydrogen bond interaction with Ser 293 similar to 
GG5 (Figs. 5 and 6).
Lipinski also laid down rules derived from the set of 1500 drugs that 
were filtered for good blood-brain barrier penetration and brain 
penetration is likely if, molecular weight ≤400 g/mol, Log p≤5, hydrogen 
bond donor ≤3, hydrogen bond acceptor ≤7 [44].
Fig. 1: p38α mitogen-activated protein kinase surface structure 
showing location of cavity containing ligand MW181 (cavity 
shown in green)
Fig. 2: p38α mitogen activated protein kinase surface structure 
showing location of cavity containing ligand GG5 (cavity shown in 
green)
Fig. 3: Isoprincepin
Fig. 4: Isoprincepin showing H-bonds with Met-109, glycine flip 
phenomenon
Fig. 5: Balonophonin
Table 1: Mean moldoc scores and re-rank scores of docked ligands of Cavity 1
Ligands Moldoc score 
kcal/mol
Rerank score 
kcal/mol
Hydrogen 
bonds
Bonding amino acids
MW181 −111.29±8.20 −79.62±5.11 3 His 107, Lys-53
Isoprincepin −141.14±3.39 −101.75±6.23 3 Met 109, Val-105, Asp-112
Moldoc and rerank scores expressed as mean±standard deviation
Table 2: Mean moldoc scores and re-rank scores of the docked ligands of Cavity 2
Ligands Moldoc score 
kcal/mol
Rerank score 
kcal/mol
Hydrogen 
bonds
Bonding amino acids
GG5 −120.31±7.36 −94.74±8.78 3 Ser-293
Balanophonin −135.27±3.41 −107.59±5.40 4 Ser-293, Ser-251, Ser-252
Isoprincepin −177.52±6.22 −133.60±10.59 3 Ser-293, Ser-251, Ser-254
Moldoc and rerank scores expressed as mean±standard deviation
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Based on physiochemical parameters balanophonin has good potential 
to cross blood brain barrier and to be a p38α MAPK inhibitors in brain 
(Table 3).
Blocking of p38α MAPK can alleviate inflammation in brain and 
periphery through cytokines and also Tau hyperphosphorylation and 
thereby amyloid formation in the brain. Both of these properties of 
M. citrifolia were experimentally observed [27-29]. Hence, there is 
a high likely hood that some phytochemicals in M. citrifolia may act 
through inhibition of p38α MAPK. Drugs inhibiting various targets like 
acetylcholinesterase, gamma- and beta secretases, have been tried in 
Alzheimer disease [45,46]. Some of the phytochemicals of M. citrifolia 
may act through these targets also and need further investigation. 
A comparative study in rabbits between M. citrifolia and memantine 
(a established drug for Alzheimer’s disease) on neurodegenerative 
disorder model suggests that M. citrifolia extract was superior to 
memantine in alleviating neuro-degeneration hence making it a 
remedy worth investigating [47]. Our screening study shows that the 
phytochemicals in M. citrifolia may bind to two different active sites 
in p38 MAPK with better stability compared to the known ligands 
and thereby are more likely to possess p38 MAPK inhibition property 
as per docking scores. Literature search revealed that extract of 
Aquilaria crassna which is a mixture of various phytochemicals of 
which balanophonin is also a component inhibited lipopolysaccharide-
induced TNF-α production by attenuating p38 MAPK activation [48]. 
No such literature exists for isoprincepin containing plant extracts. 
Though literature search showed various studies which have elicited 
anti-inflammatory and anti-neurodegenerative actions of M. citrifolia, 
there are no significant studies which looked into the molecular 
mechanism of above actions and the phytochemicals which contribute 
to these properties. In our study, we have evaluated one such possible 
mechanism of action of phytochemicals in M. citrifolia.
CONCLUSION
Based on docking study of the 22 phytochemicals present in M. citrifolia 
fruit which were screened, isoprincepin and balanophonin may 
have p38α MAPK binding potential. Balanophonin has favorable 
physiochemical properties for blood-brain barrier penetration while 
isoprincepin may show high selectivity for p38α MAPK by bonding to 
Met 109 and thereby causing glycine flip phenomenon. There may be 
a synergistic action of these phytochemicals upon various active sites 
in p38α MAPK.
ACKNOWLEDGMENT
The author is thankful to CLC Bio, Denmark for providing MVD trial 
version, January 2014 with which the study has been done. The author 
is thankful to Abhinand Varman, Sri Ramachandra University for his 
help in the study.
REFERENCES
1. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, 
et al. A protein kinase involved in the regulation of inflammatory 
cytokine biosynthesis. Nature 1994;372(6508):739-46.
2. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted 
by endotoxin and hyperosmolarity in mammalian cells. Science 
1994;265(5173):808-11.
3. Han J, Lee JD, Tobias PS, Ulevitch RJ. Endotoxin induces rapid protein 
tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 
1993;268(33):25009-14.
4. Ono K, Han J. The p38 signal transduction pathway: Activation and 
function. Cell Signal 2000;12(1):1-13.
5. Li M, Liu J, Zhang C. Evolutionary history of the vertebrate mitogen 
activated protein kinases family. PLoS One 2011;6(10):e26999.
6. Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signalling 
in cardiac hypertrophy: Dichotomy between cultured myocytes and 
animal models. J Mol Cell Cardiol 2003;35(12):1385-94.
7. Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and p38 
mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol 
Cell Biol 1998;18(6):3518-26.
8. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, et al. Cardiac 
muscle cell hypertrophy and apoptosis induced by distinct members 
of the p38 mitogen-activated protein kinase family. J Biol Chem 
1998;273(4):2161-8.
9. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, 
Glembotski CC. A role for the p38 mitogen-activated protein kinase 
pathway in myocardial cell growth, sarcomeric organization, and 
cardiac-specific gene expression. J Cell Biol 1997;139(1):115-27.
10. Marber MS, Rose B, Wang Y. The p38 mitogen-activated protein kinase 
pathway – A potential target for intervention in infarction, hypertrophy, 
and heart failure. J Mol Cell Cardiol 2011;51(4):485-90.
11. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, 
et al. Inhibition of p38 mitogen-activated protein kinase decreases 
cardiomyocyte apoptosis and improves cardiac function after myocardial 
ischemia and reperfusion. Circulation 1999;99(13):1685-91.
12. Ren J, Zhang S, Kovacs A, Wang Y, Muslin AJ. Role of p38alpha MAPK 
in cardiac apoptosis and remodelling after myocardial infarction. J Mol 
Cell Cardiol 2005;38(4):617-23.
13. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting 
the global burden of Alzheimer’s disease. Alzheimers Dement 
2007;3(3):186-91.
14. Hanger DP, Anderton BH, Noble W. Tau phosphorylation: The 
therapeutic challenge for neurodegenerative disease. Trends Mol Med 
2009;15(3):112-9.
15. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. 
Tau mislocalization to dendritic spines mediates synaptic dysfunction 
independently of neurodegeneration. Neuron 2010;68(6):1067-81.
16. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Tau 
protein isoforms, phosphorylation and role in neurodegenerative 
disorders. Brain Res Brain Res Rev 2000;33(1):95-130.
17. Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, 
et al. The high-affinity HSP90-CHIP complex recognizes and 
selectively degrades phosphorylated tau client proteins. J Clin Invest 
2007;117(3):648-58.
18. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K. 
Phosphorylation of tau at both Thr 231 and Ser 262 is required for 
maximal inhibition of its binding to microtubules. Arch Biochem 
Biophys 1998;357(2):299-309.
19. Pyo H, Jou I, Jung S, Hong S, Joe EH. Mitogen-activated protein 
kinases activated by lipopolysaccharide and beta-amyloid in cultured 
rat microglia. Neuroreport 1998;9(5):871-4.
20. Munoz L, Ranaivo H, Roy S. A novel p38α MAPK inhibitor suppresses 
brain proinflammatory cytokine upregulation and attenuates synaptic 
dysfunction and behavioural deficits in an Alzheimer’s disease mouse 
model. J Neuroinflammation 2007;4(1):84-6.
Fig. 6: Balanophonin in Cavity 2, secondary structure view
Table 3: Physiochemical properties
Properties Isoprincepin Balanophonin
Molecular weight g/mol 494.48994 356.3692
Log P 2.3 2
Hydrogen bond donor 5 2
Hydrogen bond acceptor 9 6
Rotatable bond count 4 6
Asian J Pharm Clin Res, Vol 8, Issue 6, 2015, 141-145
 Markandeyan et al. 
145
21. Kim SH, Smith CJ, Van Eldik LJ. Importance of MAPK pathways for 
microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol 
Aging 2004;25(4):431-9.
22. Bodles AM, Barger SW. Secreted beta-amyloid precursor protein 
activates microglia via JNK and p38-MAPK. Neurobiol Aging 
2005;26(1):9-16.
23. Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, 
et al. Alpha-synuclein activates stress signalling protein kinases in 
THP-1 cells and microglia. Neurobiol Aging 2008;29(5):739-52.
24. Hoareau L, Bencharif K, Rondeau P, Murumalla R, Ravanan P, 
Tallet F, et al. Signalling pathways involved in LPS induced TNFalpha 
production in human adipocytes. J Inflamm (Lond) 2010;7(1):1.
25. Krauss B. Plants in Hawaiian Culture. Hawaii: University of Hawaii 
Press; 1993. p. 103-25.
26. Whistler WA. Traditional and herbal medicine in the Cook Islands. 
J Ethnopharmacol 1985;13(3):239-80.
27. Muralidharan P, Kumar VR, Balamurugan G. Protective effect of 
Morinda citrifolia fruits on beta-amyloid (25-35) induced cognitive 
dysfunction in mice: An experimental and biochemical study. Phytother 
Res 2010;24(2):252-8.
28. Xu J, McSloy AC, Anderson BK, Godbee RG, Peek SF, Darien BJ. 
Tahitian noni equine essentials: A novel anti-inflammatory and 
a COX-2 inhibitor which regulates LPS-induced inflammatory 
mediator expression in equine neonatal monocytes. J Vet Intern Med 
2006;20(3):756-7.
29. Hokama Y. The effect of Noni fruit extract (Morinda citrifolia, Indian 
mulberry) on thymocytes of BALB/c mouse. FASEB J 1993;7(1):866-8.
30. Thomsen R, Christensen MH. MolDock: A new technique for high-
accuracy molecular docking. J Med Chem 2006;49(11):3315-21.
31. Watterson DM, Grum-Tokars VL, Roy SM, Schavocky JP, Bradaric BD, 
Bachstetter AD, et al. Development of novel in vivo chemical probes to 
address CNS protein kinase involvement in synaptic dysfunction. PLoS 
One 2013;8(6):e66226.
32. Potterat O, Hamburger M. Morinda citrifolia (Noni) fruit – 
Phytochemistry, pharmacology, safety. Planta Med 2007;73(3):191-9.
33. Farine JP, Legal L, Moreteau B, Quere JL. Volatile compounds of 
ripe fruits of Morinda citrifolia and their effects on Drosophila. 
Phytochemistry 1996;41(1):433-8.
34. Kim SW, Jo BK, Jeong JH, Choi SU, Hwang YI. Induction of 
extracellular matrix synthesis in normal human fibroblasts by 
anthraquinone isolated from Morinda citrifolia (Noni) fruit. J Med 
Food 2005;8(4):552-5.
35. Deng S, West BJ, Palu AK, Zhou BN, Jensen CJ. Noni as an anxiolytic 
and sedative: A mechanism involving its gamma-aminobutyric 
acidergic effects. Phytomedicine 2007;14(7-8):517-22.
36. Leistner E. Isolation, identification and biosynthesis of anthraquinones 
in cell suspension cultures of Morinda citrifolia (author’s transl). Planta 
Med 1975;Suppl:214-24.
37. Kamiya K, Tanaka Y, Endang H, Umar M, Satake T. New anthraquinone 
and iridoid from the fruits of Morinda citrifolia. Chem Pharm Bull 
(Tokyo) 2005;53(12):1597-9.
38. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental 
and computational approaches to estimate solubility and permeability 
in drug discovery and development settings. Adv Drug Deliv Rev 
1997;23:3-25.
39. Yang, JM, Chen, C. GEMDOCK: A Generic Evolutionary Method for 
Molecular Docking. Proteins 2004; 55:288- 304.
40. Xing L, Shieh HS, Selness SR, Devraj RV, Walker JK, Devadas B, 
et al. Structural bioinformatics-based prediction of exceptional 
selectivity of p38 MAP kinase inhibitor PH-797804. Biochemistry 
2009;48(27):6402-11.
41. Martz KE, Dorn A, Baur B, Schattel V, Goettert MI, Mayer-
Wrangowski SC, et al. Targetting the hinge glycine flip and the 
activation loop: Novel approach to potent p38a inhibitors. J Med Chem 
2012;55(17):7862-74.
42. Patel SB, Cameron PM, O’Keefe SJ, Frantz-Wattley B, Thompson J, 
O’Neill EA, et al. The three-dimensional structure of MAP kinase 
p38beta: Different features of the ATP-binding site in p38beta compared 
with p38alpha. Acta Crystallogr D Biol Crystallogr 2009;65:777-85.
43. Kusakabe K, Ide N, Daigo Y, Itoh T, Higashino K, Okano Y, et al. 
Diaminopyridine-based potent and selective mps1 kinase inhibitors 
binding to an unusual flipped-Peptide conformation. ACS Med Chem 
Lett 2012;3(7):560-4.
44. Pajouhesh H, Lenz GR. Medicinal chemical properties of successful 
central nervous system drugs. NeuroRx 2005;2(4):541-53.
45. Dewachter I, Van Leuven F. Secretases as targets for the treatment of 
Alzheimer’s disease: The prospects. Lancet Neurol 2002;1(7):409-16.
46. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane 
Database Syst Rev 2006;(1):CD005593.
47. Köktürk S, Ceylan S, Etus V, Yasa N, Ceylan S. Morinda citrifolia L. 
(noni) and memantine attenuate periventricular tissue injury of 
the fourth ventricle in hydrocephalic rabbits. Neural Regen Res 
2013;8(9):773-82.
48. Kumphune S, Prompunt E, Phaebuaw K, Sriudwong P, Pankla R, 
Thongyoo P. Anti-inflammatory effects of the ethyl acetate extract of 
Aquilaria crassna inhibits LPS-induced tumor necrosis factor-alpha 
production by attenuating p38 MAPK activation. Int J Green Pharm 
2011;5:43-8.
